Parnax Lab

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE383L01019
  • NSEID:
  • BSEID: 506128
INR
165.20
2.5 (1.54%)
BSENSE

May 07

BSE+NSE Vol: 4.47 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 286243,
    "name": "Parnax Lab",
    "stock_name": "Parnax Lab",
    "full_name": "Parnax Lab Ltd",
    "name_url": "stocks-analysis/parnax-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "165.20",
    "chg": 2.5,
    "chgp": "1.54%",
    "dir": 1,
    "prev_price": "162.70",
    "mcapval": "189.74 Cr",
    "mcap": "Micro Cap",
    "scripcode": 506128,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "indexname": "India SENSEX",
    "isin": "INE383L01019",
    "curr_date": "May 07",
    "curr_time": "",
    "bse_nse_vol": "4.47 k",
    "exc_status": "Active",
    "traded_date": "May 07, 2026",
    "traded_date_str": "2026 05 07",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/parnax-lab-286243-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Parnax Lab Ltd Valuation Shifts Signal Changing Market Perception",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parnax-lab-ltd-valuation-shifts-signal-changing-market-perception-3978629",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ParnaxLabLtd_valuationdot_3978629.png",
        "date": "2026-05-07 08:00:38",
        "description": "Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change comes amid a strong rally in its stock price, which has outperformed the Sensex significantly over multiple time horizons. Investors and analysts are now reassessing the company’s price attractiveness in light of its current price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to historical averages and peer benchmarks."
      },
      {
        "title": "Parnax Lab Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-is-rated-hold-by-marketsmojo-3966549",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ParnaxLabLtd_mojoScore_3966549.png",
        "date": "2026-04-28 10:10:03",
        "description": "Parnax Lab Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with the most recent insights into the company’s performance and outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Parnax Lab Ltd to 52-Week High of Rs 169",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parnax-lab-ltd-hits-new-52-week-high-at-rs169-3966085",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ParnaxLabLtd_priceRelatedfactors_3966085.png",
        "date": "2026-04-28 09:40:31",
        "description": "With a 71.43% gain over the past year, Parnax Lab Ltd has surged from Rs 85.60 to a fresh 52-week high of Rs 169 on 28 Apr 2026, showcasing a remarkable price momentum that outpaces the Sensex’s decline of 3.70% over the same period."
      },
      {
        "title": "Parnax Lab Ltd Valuation Shifts to Fair Amid Strong Market Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parnax-lab-ltd-valuation-shifts-to-fair-amid-strong-market-returns-3954793",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ParnaxLabLtd_valuationdot_3954793.png",
        "date": "2026-04-21 08:00:17",
        "description": "Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. Despite this adjustment, the company’s stock has delivered robust returns over multiple time horizons, outperforming the Sensex significantly. This article analyses the recent valuation changes, compares key metrics with peers, and assesses the implications for investors."
      },
      {
        "title": "Parnax Lab Ltd Gains 10.47%: 3 Key Factors Driving the Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parnax-lab-ltd-gains-1047-3-key-factors-driving-the-surge-3952816",
        "imagepath": "",
        "date": "2026-04-19 10:00:40",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>13 Apr:</strong> Stock opens week at Rs.140.15, down 1.16%</p>\n                    <p><strong>15 Apr:</strong> Valuation shifts to fair amid strong market returns</p>\n                    <p><strong>16 Apr:</strong> New 52-week high of Rs.148 reached</p>\n                    <p><strong>17 Apr:</strong> New 52-week high of Rs.166 achieved, week closes at Rs.156.65</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.141.80</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.156.65</div><div cl..."
      },
      {
        "title": "Parnax Lab Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-is-rated-hold-3950843",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ParnaxLabLtd_mojoScore_3950843.png",
        "date": "2026-04-17 10:10:03",
        "description": "Parnax Lab Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 April 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Parnax Lab Ltd to 52-Week High of Rs 166",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parnax-lab-ltd-hits-new-52-week-high-at-rs166-3950393",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ParnaxLabLtd_priceRelatedfactors_3950393.png",
        "date": "2026-04-17 09:41:14",
        "description": "With a decisive surge to Rs 166 on 17 Apr 2026, Parnax Lab Ltd has reached a fresh 52-week high, marking a 55.29% gain over the past year and outpacing the Sensex’s modest decline of 0.59%. This rally is underpinned by a strong alignment of technical indicators and sustained price momentum, even as the broader market trades cautiously."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Parnax Lab Ltd to 52-Week High of Rs 148",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parnax-lab-ltd-hits-new-52-week-high-of-rs148-on-16-apr-2026-3949294",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ParnaxLabLtd_priceRelatedfactors_3949294.png",
        "date": "2026-04-16 11:40:06",
        "description": "Surging past its previous peak, Parnax Lab Ltd touched a fresh 52-week high of Rs 148 on 16 Apr 2026, marking a significant milestone in its price momentum. This rally reflects a confluence of bullish technical indicators and a strong recovery from its 52-week low of Rs 85.6, underscoring the stock’s robust upward trajectory amid a mixed broader market backdrop."
      },
      {
        "title": "Parnax Lab Ltd Valuation Shifts to Fair Amid Strong Market Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parnax-lab-ltd-valuation-shifts-to-fair-amid-strong-market-returns-3946408",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ParnaxLabLtd_valuationdot_3946408.png",
        "date": "2026-04-15 08:00:38",
        "description": "Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation grade shift from attractive to fair, reflecting a notable change in price attractiveness. With a current price of ₹141.50 and a price-to-earnings (P/E) ratio of 12.05, the company’s valuation metrics now suggest a more balanced outlook compared to its historical and peer benchmarks. This article delves into the valuation dynamics, peer comparisons, and the implications for investors amid a backdrop of strong stock returns relative to the Sensex."
      }
    ],
    "total": 278,
    "sid": "286243",
    "stock_news_url": "https://www.marketsmojo.com/news/parnax-lab-286243"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "08-Apr-2026",
      "details": "Please find enclosed herewith the Compliance Certificate under regulation 74(5) of SEBI (DP) Regulation 2018.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Mar-2026",
      "details": "The Trading Window for dealing in securities will be closed for all the Insiders Designated Persons and their Immediate Relatives w.e.f. 01st April 2026 and shall open 48 hours after the Audited Financial Results for the Quarter and Year ended March 30 2026 become generally available to he public.",
      "source": "BSE"
    },
    {
      "caption": "Financial Results For The Quarter Ended December 31 2025.",
      "datetime": "13-Feb-2026",
      "details": "Financial Results for the Quarter Ended December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Parnax Lab Ltd Gains 10.47%: 3 Key Factors Driving the Surge

2026-04-19 10:00:40

Key Events This Week

13 Apr: Stock opens week at Rs.140.15, down 1.16%

15 Apr: Valuation shifts to fair amid strong market returns

16 Apr: New 52-week high of Rs.148 reached

17 Apr: New 52-week high of Rs.166 achieved, week closes at Rs.156.65

stock-recommendationAnnouncement

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

08-Apr-2026 | Source : BSE

Please find enclosed herewith the Compliance Certificate under regulation 74(5) of SEBI (DP) Regulation 2018.

Closure of Trading Window

27-Mar-2026 | Source : BSE

The Trading Window for dealing in securities will be closed for all the Insiders Designated Persons and their Immediate Relatives w.e.f. 01st April 2026 and shall open 48 hours after the Audited Financial Results for the Quarter and Year ended March 30 2026 become generally available to he public.

Financial Results For The Quarter Ended December 31 2025.

13-Feb-2026 | Source : BSE

Financial Results for the Quarter Ended December 31 2025.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available